{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:30Z","timestamp":1787009850767,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/aog.0000000000000640","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T08:32:53Z","timestamp":1420705973000},"page":"363-368","source":"Crossref","is-referenced-by-count":88,"title":["Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy"],"prefix":"10.1097","volume":"125","author":[{"given":"Samantha L.","family":"Wiegand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Stuebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendree","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Seashore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management.","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"Opioid abuse, dependence, and addiction in pregnancy. Committee Opinion No. 524. American College of Obstetricians and Gynecologists.","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R4-12-20210126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome.","volume":"24","author":"Jansson","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"R5-12-20210126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":". Treatment of opioid-dependent pregnant women: clinical and research issues.","volume":"35","author":"Jones","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R6-12-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses.","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 1","key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00005344-198300051-00002","article-title":"Intrinsic activity: partial agonists and partial antagonists.","volume":"5","author":"Ariens","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"issue":"suppl 1","key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":". Buprenorphine treatment opioid-dependent pregnant women: a comprehensive review.","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":". Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.","volume":"349","author":"Fudala","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11920-000-0012-8","article-title":"Buprenorphine and naloxone for heroin dependence.","volume":"2","author":"Johnson","year":"2000","journal-title":"Curr Psychiatry Rep"},{"key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.","volume":"22","author":"Debelak","year":"2013","journal-title":"Am J Addict"},{"key":"R13-12-20210126","first-page":"61","article-title":". A Comparison of Buprenorphine Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes.","volume":"7","author":"Lund","year":"2013","journal-title":"Subst Abuse"},{"key":"R14-12-20210126","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management.","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hup.1224","article-title":". Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.","volume":"26","author":"Metz","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"R16-12-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":". Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":". Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1542\/peds.2009-0913","article-title":"New intrauterine growth curves based on United States data.","volume":"125","author":"Olsen","year":"2010","journal-title":"Pediatrics"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/ANC.0000000000000033","article-title":"Validation of the Finnegan neonatal abstinence syndrome tool-short form.","volume":"13","author":"Maguire","year":"2013","journal-title":"Adv Neonatal Care"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/ANC.0b013e318241bd73","article-title":"Implementing practice guidelines and education to improve care of infants with neonatal abstinence syndrome.","volume":"12","author":"Lucas","year":"2012","journal-title":"Adv Neonatal Care"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T08:42:08Z","timestamp":1717663328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201502000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000640","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}